Skip to main content
Equibles
IKT logo

IKT · Inhibikase Therapeutics, Inc. · Exempt Offerings

Track IKT — free

Use IKT with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research IKT.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$1.53 -0.10 (-6.13%) At close · Nov 12 Q2 2024 earnings call transcript
Russell 2000 member Rebalance outlook locked
Market Cap
$214.61M
Shares
140.27M
Volume · Nov 12 728.31K Avg daily vol (3M) 566.38K

Private capital raises reported to the SEC on Form D under Regulation D, showing the offering size, amount sold, minimum investment and number of investors. Public operating companies rarely raise capital this way, so this page is often empty.

Filed Type Offering Sold
2024-06-04 New $7,999,999 $0
2023-02-07 New $4,200,000 $4,200,000
Showing 1–2 of 2 filings
Key facts CIK 1750149 CUSIP 45719W205 13F (30d) 48 filings 45 filers Visit website Investor relations